Soleimani S, Pouresmaeili F, Salahshoori Far I
Iran J Biotechnol. 2024; 22(3):e3853.
PMID: 39737204
PMC: 11682528.
DOI: 10.30498/ijb.2024.432171.3853.
Dong Y, He Y, Geng Y, Wei M, Zhou X, Lian J
Cancer Cell Int. 2024; 24(1):328.
PMID: 39342235
PMC: 11439232.
DOI: 10.1186/s12935-024-03503-1.
Elimam H, Eldeib M, Kizilaslan E, Alhamshry N, Ashour A, Elfar N
Naunyn Schmiedebergs Arch Pharmacol. 2024; 398(2):1243-1263.
PMID: 39287672
DOI: 10.1007/s00210-024-03425-9.
Chen P, Chang P, Yeh W, Hu T, Hong Y, Wang Y
Am J Cancer Res. 2024; 14(5):2103-2123.
PMID: 38859837
PMC: 11162664.
DOI: 10.62347/IMBV8599.
Kang Y, Li H, Liu Y, Li Z
J Cancer Res Clin Oncol. 2024; 150(5):221.
PMID: 38687357
PMC: 11061008.
DOI: 10.1007/s00432-024-05714-5.
Unveiling dysregulated lncRNAs and networks in non-syndromic cleft lip with or without cleft palate pathogenesis.
Wu C, Liu H, Zhan Z, Zhang X, Zhang M, You J
Sci Rep. 2024; 14(1):1047.
PMID: 38200098
PMC: 10781966.
DOI: 10.1038/s41598-024-51747-8.
SCF-FBXL8 contributes to liver metastasis and stem-cell-like features in colorectal cancer cells by mediating ubiquitination and degradation of TP53.
Yao J, Wang X, Yang J, Yang Z, Zhang Z
Clin Transl Med. 2023; 13(3):e1208.
PMID: 36855778
PMC: 9975457.
DOI: 10.1002/ctm2.1208.
Non-coding RNAs as Biomarkers for Survival in Colorectal Cancer Patients.
Andrabi M, Kesavan Y, Ramalingam S
Curr Aging Sci. 2023; 17(1):5-15.
PMID: 36733201
DOI: 10.2174/1874609816666230202101054.
Comprehensive landscape and future perspectives of long noncoding RNAs (lncRNAs) in colorectal cancer (CRC): Based on a bibliometric analysis.
He J, Wu W
Noncoding RNA Res. 2022; 8(1):33-52.
PMID: 36311994
PMC: 9582894.
DOI: 10.1016/j.ncrna.2022.10.001.
LncRNA JPX Promotes Esophageal Squamous Cell Carcinoma Progression by Targeting miR-516b-5p/VEGFA Axis.
He Y, Hua R, Yang Y, Li B, Guo X, Li Z
Cancers (Basel). 2022; 14(11).
PMID: 35681693
PMC: 9179376.
DOI: 10.3390/cancers14112713.
LncRNA MBNL1-AS1 Represses Proliferation and Cancer Stem-Like Properties of Breast Cancer through MBNL1-AS1/ZFP36/CENPA Axis.
Ding Y, Li Y, Duan Y, Wang W, Zheng W, Cheng W
J Oncol. 2022; 2022:9999343.
PMID: 35518784
PMC: 9064507.
DOI: 10.1155/2022/9999343.
Non-coding RNA regulatory networks in post-transcriptional regulation of VEGFA in cancer.
Fontemaggi G
IUBMB Life. 2022; 75(1):30-39.
PMID: 35467790
PMC: 10084289.
DOI: 10.1002/iub.2620.
Major Role for Cellular MicroRNAs, Long Noncoding RNAs (lncRNAs), and the Epstein-Barr Virus-Encoded BART lncRNA during Tumor Growth .
Edwards R, Raab-Traub N
mBio. 2022; 13(3):e0065522.
PMID: 35435703
PMC: 9239068.
DOI: 10.1128/mbio.00655-22.
Colorectal liver metastasis: molecular mechanism and interventional therapy.
Zhou H, Liu Z, Wang Y, Wen X, Amador E, Yuan L
Signal Transduct Target Ther. 2022; 7(1):70.
PMID: 35246503
PMC: 8897452.
DOI: 10.1038/s41392-022-00922-2.
Non-Coding RNAs in Colorectal Cancer: Their Functions and Mechanisms.
Jia Z, An J, Liu Z, Zhang F
Front Oncol. 2022; 12:783079.
PMID: 35186731
PMC: 8847166.
DOI: 10.3389/fonc.2022.783079.
New insights into the interplay between long non-coding RNAs and RNA-binding proteins in cancer.
Yao Z, Yang Y, Sun M, He Y, Liao L, Chen K
Cancer Commun (Lond). 2022; 42(2):117-140.
PMID: 35019235
PMC: 8822594.
DOI: 10.1002/cac2.12254.
Transcriptional alterations of protein coding and noncoding RNAs in triple negative breast cancer in response to DNA methyltransferases inhibition.
Elango R, Vishnubalaji R, Shaath H, Alajez N
Cancer Cell Int. 2021; 21(1):515.
PMID: 34565361
PMC: 8474815.
DOI: 10.1186/s12935-021-02213-2.
Long non-coding RNAs and circular RNAs in tumor angiogenesis: From mechanisms to clinical significance.
Liu C, Li J, Xu Y, Li W, Fang S, Zhang Q
Mol Ther Oncolytics. 2021; 22:336-354.
PMID: 34553023
PMC: 8426176.
DOI: 10.1016/j.omto.2021.07.001.
Immune-Related lncRNAs to Construct Novel Signatures and Predict the Prognosis of Rectal Cancer.
Xing X, Xing C, Huang Z, Yao Z, Liu Y
Front Oncol. 2021; 11:661846.
PMID: 34485113
PMC: 8415501.
DOI: 10.3389/fonc.2021.661846.
Identification and validation of a five-lncRNA signature for predicting survival with targeted drug candidates in ovarian cancer.
Lin N, Lin J, Tanaka Y, Sun P, Zhou X
Bioengineered. 2021; 12(1):3263-3274.
PMID: 34224310
PMC: 8806566.
DOI: 10.1080/21655979.2021.1946632.